Extract from European Patent Office communication yesterday:
For the intended grant of the European patent, the bibliographic data are set out below, for information:
Title of Invention: ISOFLAVONOID COMPOSITION WITH IMPROVED PHARMACOKINETICS
Details of the application were updated by Noxopharm on 14 May, as requested by the EPO, as a prelude to the formal grant of patent protection.
Patent grant will take place when all formalities are complete.
Patent update
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.005(4.76%) |
Mkt cap ! $32.14M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.5¢ | 11.0¢ | $18.94K | 171.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 66800 | 1 |
View Market Depth
| Last trade - 14.48pm 08/11/2024 (20 minute delay) ? |
| NOX (ASX) Chart |